These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 14614641)
1. p27 expression and proliferation in gastrointestinal stromal tumors. Gelen MT; Elpek GO; Aksoy NH; Oğüş M; Süleymanlar I; Işitan F Turk J Gastroenterol; 2003 Jun; 14(2):132-7. PubMed ID: 14614641 [TBL] [Abstract][Full Text] [Related]
2. Cyclin D3 immunoreactivity in gastrointestinal stromal tumors is independent of cyclin D3 gene amplification and is associated with nuclear p27 accumulation. Pruneri G; Mazzarol G; Fabris S; Del Curto B; Bertolini F; Neri A; Viale G Mod Pathol; 2003 Sep; 16(9):886-92. PubMed ID: 13679452 [TBL] [Abstract][Full Text] [Related]
3. Increased cyclin D3 expression significantly correlates with p27 nuclear positivity in gastrointestinal stromal tumors. Draper N; Bui M; Boulware DC; Lloyd M; Chiappori AA; Pledger WJ; Coppola D Hum Pathol; 2008 Dec; 39(12):1784-91. PubMed ID: 18701138 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors. Can B; Sökmensüer C Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191 [TBL] [Abstract][Full Text] [Related]
5. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860 [TBL] [Abstract][Full Text] [Related]
6. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors. Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954 [TBL] [Abstract][Full Text] [Related]
8. Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome. Zolota V; Tsamandas AC; Aroukatos P; Panagiotopoulos V; Maraziotis T; Poulos C; Scopa CD Neuropathology; 2008 Feb; 28(1):35-42. PubMed ID: 18181833 [TBL] [Abstract][Full Text] [Related]
9. The cyclin-dependent kinase inhibitor, p27, has no correlation with the malignant potential of GIST. Shirin H; Kravtsov V; Shahmurov M; Shabat VS; Krinshpon I; Alin A; Avinoach I; Avni Y Digestion; 2007; 75(1):4-9. PubMed ID: 17406118 [TBL] [Abstract][Full Text] [Related]
10. Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma. Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y Acta Otolaryngol; 2005 Jul; 125(7):779-85. PubMed ID: 16012042 [TBL] [Abstract][Full Text] [Related]
11. Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection. Hu TH; Tai MH; Chuah SK; Chen HH; Lin JW; Huang HY; Chou YP; Yi LN; Kuo CM; Changchien CS J Surg Oncol; 2008 Aug; 98(2):117-23. PubMed ID: 18521824 [TBL] [Abstract][Full Text] [Related]
12. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms. Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405 [TBL] [Abstract][Full Text] [Related]
13. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer. Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413 [TBL] [Abstract][Full Text] [Related]
14. Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study. Sökmensüer C; Gedikoglu G; Uzunalimoglu B Hepatogastroenterology; 2001; 48(39):720-3. PubMed ID: 11462912 [TBL] [Abstract][Full Text] [Related]
15. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors]. Liang YM; Li XH; Chen W Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria. Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685 [TBL] [Abstract][Full Text] [Related]
17. p27 Labeling index and proliferation in gastrointestinal stromal tumors: correlations with clinicopathologic factors and recurrence. Gelen T; Elpek GO; Aksoy NH; Ogüş M; Keleş N Jpn J Clin Oncol; 2003 Jul; 33(7):346-52. PubMed ID: 12949061 [TBL] [Abstract][Full Text] [Related]
18. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators. Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007 [TBL] [Abstract][Full Text] [Related]
19. Correlation of enhanced cell turnover with prognosis of gastrointestinal stromal tumors of the stomach: relevance of cellularity and p27kip1. Nemoto Y; Mikami T; Hana K; Kikuchi S; Kobayashi N; Watanabe M; Okayasu I Pathol Int; 2006 Dec; 56(12):724-31. PubMed ID: 17096729 [TBL] [Abstract][Full Text] [Related]
20. Significance of p53 expression in gastrointestinal stromal tumors. Yalcinkaya U; Yerci O; Koc EU Hepatogastroenterology; 2007; 54(73):140-3. PubMed ID: 17419248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]